Scott C Howard

Author PubWeight™ 114.64‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 2009 7.95
2 Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood 2004 4.21
3 Results of therapy for acute lymphoblastic leukemia in black and white children. JAMA 2003 2.77
4 Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study. Lancet Oncol 2008 2.49
5 Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood 2010 2.37
6 Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet 2009 2.37
7 Asociación de Hemato-Oncología Pediátrica de Centro América (AHOPCA): a model for sustainable development in pediatric oncology. Pediatr Blood Cancer 2013 2.23
8 Current management and challenges of malignant disease in the CNS in paediatric leukaemia. Lancet Oncol 2008 2.14
9 Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries. Lancet 2003 2.00
10 Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia. Blood 2011 1.88
11 Development and use of active clinical decision support for preemptive pharmacogenomics. J Am Med Inform Assoc 2013 1.80
12 Changes in outcomes (1996-2004) for pediatric oncology and hematopoietic stem cell transplant patients requiring invasive mechanical ventilation. Pediatr Crit Care Med 2008 1.68
13 Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Cancer 2006 1.64
14 Impact of an education program on late diagnosis of retinoblastoma in Honduras. Pediatr Blood Cancer 2007 1.62
15 Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers. Annu Rev Pharmacol Toxicol 2014 1.58
16 Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 2005 1.53
17 Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer. J Infect Dis 2011 1.49
18 PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics. Am J Med Genet C Semin Med Genet 2014 1.49
19 Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma. JAMA 2012 1.48
20 Targeting the Bcl-2 family of proteins in Hodgkin lymphoma: in vitro cytotoxicity, target modulation and drug combination studies of the Bcl-2 homology 3 mimetic ABT-737. Leuk Lymphoma 2009 1.45
21 Global child health priorities: what role for paediatric oncologists? Eur J Cancer 2008 1.38
22 Paediatric cancer in low-income and middle-income countries. Lancet Oncol 2013 1.35
23 Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial. J Pediatr Psychol 2007 1.27
24 Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007. J Clin Oncol 2012 1.25
25 Femoral head osteonecrosis in pediatric and young adult patients with leukemia or lymphoma. J Clin Oncol 2007 1.22
26 Prognostic significance of CD20 expression in childhood B-cell precursor acute lymphoblastic leukemia. Blood 2006 1.22
27 Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children. Br J Haematol 2005 1.21
28 Establishment of ethical oversight of human research in El Salvador: lessons learned. Lancet Oncol 2006 1.19
29 Improved prognosis for older adolescents with acute lymphoblastic leukemia. J Clin Oncol 2010 1.16
30 Unsafe and violent behavior in commercials aired during televised major sporting events. Pediatrics 2004 1.16
31 Long-term efficacy of methylphenidate in enhancing attention regulation, social skills, and academic abilities of childhood cancer survivors. J Clin Oncol 2010 1.15
32 New policies to address the global burden of childhood cancers. Lancet Oncol 2013 1.12
33 Severe cardiopulmonary complications consistent with systemic inflammatory response syndrome caused by leukemia cell lysis in childhood acute myelomonocytic or monocytic leukemia. Pediatr Blood Cancer 2005 1.11
34 Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J Clin Oncol 2014 1.10
35 Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia. Blood 2006 1.10
36 Effect of race on the outcome of pediatric patients with Hodgkin's lymphoma. J Clin Oncol 2008 1.07
37 Diabetic ketoacidosis during therapy for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 2008 1.06
38 Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice? Transfus Med Rev 2007 1.03
39 MRI of knee osteonecrosis in children with leukemia and lymphoma: Part 2, clinical and imaging patterns. AJR Am J Roentgenol 2006 1.02
40 Resumption of high-dose methotrexate after acute kidney injury and glucarpidase use in pediatric oncology patients. Cancer 2012 0.99
41 Side effects of methylphenidate in childhood cancer survivors: a randomized placebo-controlled trial. Pediatrics 2009 0.97
42 Symptoms of attention-deficit/hyperactivity disorder in long-term survivors of childhood leukemia. Pediatr Blood Cancer 2011 0.96
43 Pericardial involvement at diagnosis in pediatric Hodgkin lymphoma patients. Pediatr Blood Cancer 2007 0.96
44 Comparison of gallium and PET scans at diagnosis and follow-up of pediatric patients with Hodgkin lymphoma. Pediatr Blood Cancer 2008 0.95
45 Implementation of a data management program in a pediatric cancer unit in a low income country. Pediatr Blood Cancer 2007 0.95
46 Treatment strategies and regimens of graduated intensity for childhood acute lymphoblastic leukemia in low-income countries: A proposal. Pediatr Blood Cancer 2009 0.93
47 Severe thrombocytopenia with iron deficiency anemia. Pediatr Hematol Oncol 2010 0.93
48 Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia. Cancer 2014 0.93
49 Thrombolytic therapy for central venous catheter occlusion. Haematologica 2011 0.92
50 Safe and successful implementation of CPOE for chemotherapy at a children's cancer center. J Natl Compr Canc Netw 2011 0.92
51 Effect of body mass index on the outcome of children with acute myeloid leukemia. Cancer 2012 0.90
52 Congenital right ventricular diverticulum associated with a ventricular septal defect: a rare echocardiographic finding. Echocardiography 2006 0.90
53 Initial response to salvage therapy determines prognosis in relapsed pediatric Hodgkin lymphoma patients. Cancer 2010 0.88
54 Natural history of thyroid nodules in survivors of pediatric Hodgkin lymphoma. Pediatr Blood Cancer 2006 0.87
55 Improved hydroxyurea effect with the use of text messaging in children with sickle cell anemia. Pediatr Blood Cancer 2014 0.87
56 Utility of automated counting to determine absolute neutrophil counts and absolute phagocyte counts for pediatric cancer treatment protocols. Cancer 2004 0.86
57 Growth effects of methylphenidate among childhood cancer survivors: a 12-month case-matched open-label study. Pediatr Blood Cancer 2009 0.86
58 Efficacy of glucarpidase (carboxypeptidase g2) in patients with acute kidney injury after high-dose methotrexate therapy. Pharmacotherapy 2013 0.86
59 Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies. Br J Haematol 2011 0.85
60 Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil. Pediatr Blood Cancer 2007 0.84
61 Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer 2014 0.84
62 High-risk childhood acute lymphoblastic leukemia. Clin Lymphoma Myeloma 2009 0.84
63 Delayed diagnosis of leukemia and association with morbid-mortality in children in Pernambuco, Brazil. J Pediatr Hematol Oncol 2012 0.84
64 Treatment-related mortality in children with acute myeloid leukaemia in Central America: incidence, timing and predictors. Eur J Cancer 2011 0.84
65 White race as a risk factor for hypothyroidism after treatment for pediatric Hodgkin's lymphoma. J Clin Oncol 2006 0.83
66 Treatment-related mortality in children with acute lymphoblastic leukemia in Central America. Cancer 2011 0.83
67 Prognostic impact of absolute lymphocyte counts at the end of remission induction in childhood acute lymphoblastic leukemia. Cancer 2013 0.82
68 Spinal epidural lipomatosis in children with hematologic malignancies. Ann Hematol 2011 0.82
69 Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments. Cancer Chemother Pharmacol 2013 0.82
70 Changes in medical care at a pediatric oncology referral center after placement of a do-not-resuscitate order. J Palliat Med 2010 0.82
71 POND4Kids: a global web-based database for pediatric hematology and oncology outcome evaluation and collaboration. Stud Health Technol Inform 2013 0.81
72 Use of Joint Commission International standards to evaluate and improve pediatric oncology nursing care in Guatemala. Pediatr Blood Cancer 2012 0.81
73 Barriers to cure for children with cancer in India and strategies to improve outcomes: a report by the Indian Pediatric Hematology Oncology Group. Pediatr Hematol Oncol 2014 0.81
74 POND4Kids: a web-based pediatric cancer database for hospital-based cancer registration and clinical collaboration. Stud Health Technol Inform 2011 0.81
75 Pulmonary alveolar proteinosis in pediatric leukemia. Pediatr Blood Cancer 2008 0.80
76 Outcome of children treated for relapsed acute lymphoblastic leukemia in Central America. Cancer 2012 0.80
77 Neurologic morbidity and quality of life in survivors of childhood acute lymphoblastic leukemia: a prospective cross-sectional study. J Cancer Surviv 2014 0.80
78 Low socioeconomic status is associated with prolonged times to assessment and treatment, sepsis and infectious death in pediatric fever in El Salvador. PLoS One 2012 0.80
79 Conservative management of pancreatic pseudocysts in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2009 0.80
80 Patterns of treatment failure in pediatric and young adult patients with Hodgkin's disease: local disease control with combined-modality therapy. J Clin Oncol 2005 0.80
81 Reported availability and gaps of pediatric palliative care in low- and middle-income countries: a systematic review of published data. J Palliat Med 2014 0.79
82 Itraconazole-enhanced chemotherapy toxicity in a patient with Hodgkin lymphoma. J Pediatr Hematol Oncol 2006 0.79
83 The cost effectiveness of treating paediatric cancer in low-income and middle-income countries: a case-study approach using acute lymphocytic leukaemia in Brazil and Burkitt lymphoma in Malawi. Arch Dis Child 2012 0.78
84 A sustainable model for pediatric oncology nursing education in low-income countries. Pediatr Blood Cancer 2011 0.78
85 18F-FDG-avid sites mimicking active disease in pediatric Hodgkin's. Pediatr Radiol 2004 0.78
86 Pediatric oncology research in low income countries: ethical concepts and challenges. Pediatr Blood Cancer 2011 0.77
87 Outcome of children treated for relapsed acute myeloid leukemia in Central America. Pediatr Blood Cancer 2014 0.77
88 Supportive medical care for children with acute lymphoblastic leukemia in low- and middle-income countries. Expert Rev Hematol 2015 0.77
89 Outcomes in patients with mixed phenotype acute leukemia in Morocco. J Pediatr Hematol Oncol 2014 0.77
90 Pharmacokinetics of 2-chlorodeoxyadenosine in a child undergoing hemofiltration and hemodialysis for acute renal failure. J Pediatr Hematol Oncol 2002 0.77
91 A practical approach to reporting treatment abandonment in pediatric chronic conditions. Pediatr Blood Cancer 2015 0.76
92 Abdominal compartment syndrome in a newly diagnosed patient with Burkitt lymphoma. Pediatr Radiol 2006 0.76
93 Childhood acute lymphoblastic leukemia in the Middle East and neighboring countries: a prospective multi-institutional international collaborative study (CALLME1) by the Middle East Childhood Cancer Alliance (MECCA). Pediatr Blood Cancer 2014 0.76
94 A revised classification scheme for acute transfusion reactions. Transfusion 2007 0.76
95 Watchful waiting for some children with a mediastinal mass: the potential role for ¹⁸F-fluorodeoxyglucose positron emission tomography: a case report and review of the literature. BMC Pediatr 2013 0.75
96 Utility of bone marrow biopsy at diagnosis in pediatric Hodgkin's lymphoma. Haematologica 2010 0.75
97 The weaned pig as a model for Doxorubicin-induced mucositis. Chemotherapy 2014 0.75
98 Management of children with brain tumors in Paraguay. Neuro Oncol 2012 0.75
99 Effect of allopurinol versus urate oxidase on methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia. Cancer 2010 0.75
100 Improving the prognosis of pediatric Hodgkin lymphoma in developing countries: a Moroccan Society of Pediatric Hematology and Oncology study. Pediatr Blood Cancer 2013 0.75
101 Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy. Pediatr Blood Cancer 2013 0.75
102 Myositis complicating viridans streptococcal sepsis in childhood leukemia. Pediatr Blood Cancer 2005 0.75
103 Defining and distinguishing treatment abandonment in patients with cancer. J Pediatr Hematol Oncol 2015 0.75
104 Assessing National Cancer Control Plan Knowledge, Prioritization, and Engagement Through a Pediatric Oncology Cancer Control Workshop. J Pediatr Hematol Oncol 2017 0.75
105 Hepatoblastoma and Abernethy Malformation Type I: Case Report. J Pediatr Hematol Oncol 2017 0.75
106 Safe Use of Low-Molecular-weight Heparin in Pediatric Acute Lymphoblastic Leukemia and Lymphoma Around Lumbar Punctures. J Pediatr Hematol Oncol 2017 0.75
107 Baseline mannose binding lectin levels may not predict infection among children with leukemia. Pediatr Blood Cancer 2008 0.75
108 Correlation of bone age, dental age, and chronological age in survivors of childhood acute lymphoblastic leukaemia. Int J Paediatr Dent 2008 0.75
109 Infectious complications in children with acute lymphoblastic leukemia treated in low-middle-income countries. Expert Rev Hematol 2015 0.75